NEUROCRINE BIOSCIENCES INC
NBIX
23 insider filings · Latest: May 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | Dec 31 9:17 PM | INGRID DELAET | Proposed Sale | 272 | $137.06 | $37.3K | — | View → |
| Dec 17, 2024 | Dec 17 9:29 PM | INGRID DELAET | Proposed Sale | 1,091 | $133.05 | $145.2K | — | View → |
| Nov 29, 2024 | Nov 29 6:41 PM | JUDE ONYIA | Proposed Sale | 2,331 | $126.59 | $295.1K | — | View → |
| Sep 13, 2024 | Sep 13 8:23 PM | DAVID WARREN BOYER | Proposed Sale | 4,756 | $121.28 | $576.8K | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 13, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Grant/Award | 51,830 | $124.12 | 7,735(D) | View → |
| Feb 12, 2026 | Feb 17 10:49 PM | Matt AbernethyChief Financial Officer | Option Exercise | 2,133 | — | 6,401(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 3,352 | — | 1,812(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Grant/Award | 134,972 | $124.12 | 20,142(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,907 | — | 14,721(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Grant/Award | 64,788 | $124.12 | 9,669(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 5,407 | — | 2,717(D) | View → |
| Feb 12, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 2,560 | — | 7,681(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Grant/Award | 42,652 | $124.12 | 6,365(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 4,044 | — | 2,083(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,005 | — | 6,017(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Grant/Award | 31,854 | $124.12 | 4,754(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 2,911 | — | 1,510(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,387 | — | 4,161(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Grant/Award | 41,033 | $124.12 | 6,124(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 4,100 | — | 2,083(D) | View → |
Page 1 of 2
Next →